Gail Farfel

3.6k total citations · 3 hit papers
43 papers, 2.7k citations indexed

About

Gail Farfel is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Gail Farfel has authored 43 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 14 papers in Pediatrics, Perinatology and Child Health and 13 papers in Pharmacology. Recurrent topics in Gail Farfel's work include Epilepsy research and treatment (18 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Posttraumatic Stress Disorder Research (10 papers). Gail Farfel is often cited by papers focused on Epilepsy research and treatment (18 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Posttraumatic Stress Disorder Research (10 papers). Gail Farfel collaborates with scholars based in United States, France and Belgium. Gail Farfel's co-authors include Carolyn R. Sikes, Barbara O. Rothbaum, Lewis S. Seiden, Dewleen G. Baker, Teri Pearlstein, Jonathan Davidson, Kathleen T. Brady, Bradley S. Galer, Gregory M. Asnis and Bessel A. van der Kolk and has published in prestigious journals such as The Lancet, JAMA and American Journal of Psychiatry.

In The Last Decade

Gail Farfel

42 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder

2000 502 citations Kathleen T. Brady, Teri Pearlstein et al. profile →
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

2019 249 citations Lieven Lagae, Joseph Sullivan et al. The Lancet profile →
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens

2019 180 citations Rima Nabbout, Arun Mistry et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gail Farfel United States	23	1.1k	960	768	606	590	43	2.7k
Eydie L. Moses‐Kolko United States	28	1.3k 1.1×	409 0.4×	494 0.6×	716 1.2×	258 0.4×	54	4.0k
Kenneth Alper United States	31	728 0.7×	1.6k 1.6×	977 1.3×	417 0.7×	192 0.3×	65	3.5k
Robert M. Post United States	29	662 0.6×	2.1k 2.2×	919 1.2×	469 0.8×	333 0.6×	60	3.8k
Brian C. Schweinsburg United States	28	516 0.5×	480 0.5×	613 0.8×	459 0.8×	460 0.8×	40	3.1k
Bruce R. Lawford Australia	31	470 0.4×	507 0.5×	833 1.1×	180 0.3×	317 0.5×	76	2.6k
Gianni L. Faedda United States	35	1.1k 1.0×	2.6k 2.7×	323 0.4×	177 0.3×	417 0.7×	52	3.9k
Leif Lindström Sweden	27	526 0.5×	1.3k 1.3×	862 1.1×	163 0.3×	236 0.4×	63	3.1k
Peggy J. Pazzaglia United States	20	625 0.6×	1.4k 1.5×	397 0.5×	288 0.5×	283 0.5×	37	2.3k
J.C. Ballenger United States	19	809 0.7×	846 0.9×	441 0.6×	102 0.2×	374 0.6×	196	2.2k
Trisha Suppes United States	32	981 0.9×	2.9k 3.0×	343 0.4×	130 0.2×	592 1.0×	79	4.0k

Countries citing papers authored by Gail Farfel

Since Specialization

Citations

This map shows the geographic impact of Gail Farfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Farfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Farfel more than expected).

Fields of papers citing papers by Gail Farfel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail Farfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Farfel. The network helps show where Gail Farfel may publish in the future.

Co-authorship network of co-authors of Gail Farfel

This figure shows the co-authorship network connecting the top 25 collaborators of Gail Farfel. A scholar is included among the top collaborators of Gail Farfel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail Farfel. Gail Farfel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sullivan, Joseph, Lieven Lagae, J. Helen Cross, et al.. (2023). Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo‐controlled clinical trial. Epilepsia. 64(10). 2653–2666. 31 indexed citations

Knupp, Kelly G., Ingrid E. Scheffer, Berten Ceulemans, et al.. (2022). Interim Analysis of Long-Term Safety and Efficacy of FINTEPLA (fenfluramine) in Patients with Lennox-Gastaut Syndrome (S13.010). Neurology. 98(18_supplement). 2 indexed citations

Agarwal, Anupam, Gail Farfel, Arnold R. Gammaitoni, et al.. (2022). Long-Term Cardiovascular Safety of Fenfluramine for Lennox-Gastaut Syndrome: Interim Analysis of Open-Label Safety Study (S24.005). Neurology. 98(18_supplement). 1 indexed citations

Knupp, Kelly G., Ingrid E. Scheffer, Berten Ceulemans, et al.. (2022). Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study. Epilepsia. 64(1). 139–151. 36 indexed citations

Isquith, Peter Κ., Gérard A. Gioia, Kelly G. Knupp, et al.. (2022). Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment. Epilepsy & Behavior. 138. 108994–108994. 22 indexed citations

Agarwal, Anupam, Gail Farfel, Arnold R. Gammaitoni, et al.. (2022). Long-term cardiovascular safety of fenfluramine in patients with Dravet syndrome treated for up to 3 years: Findings from serial echocardiographic assessments. European Journal of Paediatric Neurology. 39. 35–39. 21 indexed citations

Maurice, Tangui, et al.. (2022). Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo. Epilepsy & Behavior. 127. 108526–108526. 12 indexed citations

Isquith, Peter Κ., Gérard A. Gioia, Arnold R. Gammaitoni, et al.. (2021). Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome. Epilepsy & Behavior. 121(Pt A). 108024–108024. 42 indexed citations

Sullivan, Joseph, Stéphane Auvin, Milka Pringsheim, et al.. (2020). Long-Term (2-Year) Safety and Efficacy of Adjunctive ZX008 (Fenfluramine Hydrochloride Oral Solution) for Dravet Syndrome: Interim Results of an Ongoing Open-Label Extension Study (4684). Neurology. 94(15_supplement). 5 indexed citations

10.

Lagae, Lieven, Joseph Sullivan, Kelly G. Knupp, et al.. (2019). Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. The Lancet. 394(10216). 2243–2254. 249 indexed citations breakdown →

11.

Rasmusson, Ann M., Christine E. Marx, Sonia Jain, et al.. (2017). A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology. 234(15). 2245–2257. 45 indexed citations

12.

Friedman, Matthew J., Charles R. Marmar, Dewleen G. Baker, Carolyn R. Sikes, & Gail Farfel. (2007). Randomized, Double-Blind Comparison of Sertraline and Placebo for Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting. The Journal of Clinical Psychiatry. 68(5). 711–720. 174 indexed citations

13.

Davidson, Jonathan, Lawrence R. Landerman, Gail Farfel, & Cathryn M. Clary. (2002). Characterizing the effects of sertraline in post-traumatic stress disorder. Psychological Medicine. 32(4). 661–670. 47 indexed citations

14.

Davidson, Jonathan, Barbara O. Rothbaum, Bessel A. van der Kolk, Carolyn R. Sikes, & Gail Farfel. (2001). Multicenter, Double-blind Comparison of Sertraline and Placebo in the Treatment of Posttraumatic Stress Disorder. Archives of General Psychiatry. 58(5). 485–485. 342 indexed citations

15.

Davidson, Jonathan, Teri Pearlstein, Peter D. Londborg, et al.. (2001). Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study. American Journal of Psychiatry. 158(12). 1974–1981. 149 indexed citations

16.

Goldstein, S., et al.. (1998). Double-blind flexible dose multicenter study of sertraline and placebo in outpatients with post-traumatic stress disorder. European Neuropsychopharmacology. 8. S261–S261. 3 indexed citations

17.

Farfel, Gail & Lewis S. Seiden. (1995). Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan.. Journal of Pharmacology and Experimental Therapeutics. 272(2). 860–867. 103 indexed citations

18.

Farfel, Gail & Lewis S. Seiden. (1995). Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.. Journal of Pharmacology and Experimental Therapeutics. 272(2). 868–875. 97 indexed citations

19.

Farfel, Gail, Georgetta Vosmer, & Lewis S. Seiden. (1992). The N-methyl-d-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Brain Research. 595(1). 121–127. 44 indexed citations

20.

Farfel, Gail, et al.. (1992). Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Research. 578(1-2). 235–243. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact